The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy
Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Osteosarcoma | Taxotere